Master Alliance Provisions Guide (MAPGuide)

CSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement

  • Equitable Access | Affordable pricing



8.2. Licences and sublicences

MPP and CSIC will discuss and agree upon the identities of interested and suitable Third Parties to whom MPP shall grant sublicences for the purposes of developing, fabricating and/or Commercialising the Product. MPP will require in the sublicences that sublicensee(s) use commercially reasonable efforts to ensure that the Product(s) be made available in LMICs at affordable pricing.